Search
California Center for Pituitary Disorders
The California Center for Pituitary Disorders is the largest practice for pituitary disorders in the United States & performs more pituitary surgeries than any other medical center in the U.S.Cancer Services Referral Directory
One of the primary objectives at the UCSF Helen Diller Family Comprehensive Cancer Center is to be a partner in care, supporting patients’ treatments and providing physicians with efficient access to our services.2019-20 Referral Services Guide
UCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.Oral Dysplasia Program
Oral dysplasia patients at UCSF benefit from an internationally recognized team of multidisciplinary experts with the highest level of expertise in this difficult-to-manage and often unpredictable disease.Adrenal Tumors and Posterior Retroperitoneoscopic Adrenalectomy (PRA): A Case Study
Sanziana Roman, MD, an endocrine surgeon, discusses a patient’s treatment for a tumor in the retroperitoneum, near the adrenal gland.Pancreas Center
Novel therapeutics and state-of-the-art surgical techniques combined with an array of support services for patientsCase Study: Multiple Myeloma and Novel Immunotherapy Approaches
Hematologist Nina Shah discusses the treatment plan of a patient diagnosed with a smoldering multiple myeloma (MM).Incorporating Clinical Trials Into Patient Care: A Unique Approach to Treating Head & Neck Cancer
With the advent of immunotherapy, UCSF physicians are incorporating clinical trials into head and neck cancer patient care and changing the treatment paradigm.Hematology and Blood and Marrow Transplant
Specialized treatments for acute and chronic blood conditions, from cancers to the full range of non-malignant blood disordersHead and Neck Surgical Oncology
Expert care to improve both survival and quality of lifeMelanoma and Skin Cancer Program
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancersCAR-T Cell Therapy Treatment and Research
UCSF is a leader in the newest forms of cellular immunotherapy, which have been shown to be particularly effective in the treatment of B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL).Breast Oncology
Expert care and transformative research working together to improve both survival and quality of lifeMinimally Invasive and Robotic Thoracic Surgery
UCSF Health offers a robotic thoracic surgery program specializing in treating thoracic disease.Breast MRI and Advanced Breast Intervention
Bonnie Joe, MD, PhD, discusses how breast MRI is performed, common indications for breast MRI and advanced methods for biopsy and pre-surgical localization of tumors.Mammography 101
Bonnie Joe, MD explains the differences between screening and diagnostic mammography, shows evidence for screening, answers common questions about radiation risk and false positives and discusses digital breast tomosynthesis, also known as 3D mammography.Cancer Immunotherapy: Promise and Pitfalls
Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.Salivary Gland Transfer for Head & Neck Cancer Patients
Discover the surprising way a simple surgery can vastly improve quality of life for head and neck cancer patients after radiation treatment. How? By moving the submandibular gland out of the way of the most intense radiation to prevent xerostomia.Personalized Therapy for Early-Stage Lung Cancer at UCSF
Follow the journey of a UCSF patient with early-stage, high-risk lung cancer, from history to treatment and prognosis, including how surgeons chose to do a robotic assisted VATS lobectomy and an analysis of how well chemo is likely to work for her.Updates from the American Society of Clinical Oncology (ASCO) 2017
A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope RugoThe Human Microbiome and Breast Cancer
Immunologist Michael Campbell and breast cancer surgeon Laura Esserman speak at the April 2017 Bay Area Breast Cancer Forum about the human biome, how it’s being studied and how it relates to breast cancer prevention and treatment.Multiple Myeloma: Cutting-Edge Induction and Maintenance Therapies Lead to Improved Response Rates and Survival for Newly Diagnosed Patients
Take a deep dive into therapy options for newly diagnosed myeloma patients: whether three drugs are better than two, the case for lenalidomide maintenance therapy, the many improvements in induction treatment, the future of immunotherapy, and more.